Professor Ian Weeks

Overview

Research and development of in vitro diagnostic methods based on ligand binding assays such as immunoassay, nucleic acid hybridisation assay and enzymological assay using high sensitivity end-points such as chemiluminescence. Particular emphasis on development of simple, non-invasive methods as alternatives to invasive clinical test procedures. Current research involves the application of the principles outlined above for the development of diagnostic tests for biomarkers of inflammation and cancer.

The overarching strategic model for the research is to target areas where there is an unmet clinical need or where synergy of technologies can enhance clinical diagnosis and management of underlying pathologies. Such a strategy is beneficial to patients and cost-effective for the healthcare provider.